Abstract Details

Title Steady-State Bioequivalence of Extended-Release Once-Daily SPN-538 (Trokendi XR™) to Immediate-Release Topiramate (TPM-IR, Topamax®)

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) (-)

Poster/Presentation
Number 245

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Janet Johnson PRESENTER	No disclosure on file
Adam J. Simon, PhD (Cerora Inc)	No disclosure on file
Scott Brittain (Supernus Pharmaceuticals, Inc.)	No disclosure on file
	No disclosure on file
Paolo Baroldi (Supernus Pharmaceuticals, Inc.)	No disclosure on file

�鶹��ýӳ��